Следене
Eleonora Dimitrova
Eleonora Dimitrova
Потвърден имейл адрес: mu-varna.bg
Заглавие
Позовавания
Позовавания
Година
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer
MP Petrova, MI Eneva, JI Arabadjiev, NV Conev, EG Dimitrova, ...
Bioscience trends 14 (1), 48-55, 2020
552020
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer
MP Petrova, IS Donev, MA Radanova, MI Eneva, EG Dimitrova, ...
Clinical & Experimental Immunology 202 (3), 353-362, 2020
372020
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer
NV Conev, YK Kashlov, EG Dimitrova, YK Kashlov, MK Bogdanova, ...
Clinical and Investigative Medicine 42 (1), E31-E38, 2019
312019
Association between serum CK-18 levels and the degree of liver damage in fructose-induced metabolic syndrome
K Bratoeva, S Nikolova, A Merdzhanova, GS Stoyanov, E Dimitrova, ...
Metabolic syndrome and related disorders 16 (7), 350-357, 2018
202018
1698P The presence of COVID-19 makes more cancer patients distressed and time perception may distinguish them
NV Conev, M Petrova, E Dimitrova, K Zhelev, ZI Zahariev, K Nikolov, ...
Annals of Oncology 31, S1002, 2020
42020
Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's …
EG Dimitrova, BG Chaushev, NV Conev, JK Kashlov, AK Zlatarov, ...
Bioscience trends 11 (2), 221-228, 2017
42017
KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
M Radanova, G Mihaylova, GS Stoyanov, V Draganova, A Zlatarov, ...
International Journal of Molecular Sciences 24 (16), 12753, 2023
32023
Time perception as a novel ultra-short screening tool for distress in cancer patients.
NV Conev, I Donev, D Stoyanov, M Ivanova, E Dimitrova, A Yanchev
Journal of Clinical Oncology 36 (15_suppl), e22123-e22123, 2018
22018
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies
G Todorov, C Bachvarov, G Valchev, N Kolev, A Tonev, V Ignatov, ...
Varna Medical Forum 7 (1), 11-14, 2018
12018
Embolization of bronchial arteries in cases of life-threatening bleeding
G Todorov, C Bachvarov, G Valchev, R Popova, A Antonov, S Sirakov, ...
Heart-Lung (Varna) 21 (1-2), 45-49, 2015
12015
Sensory profiling of dairy starch dessert creams enhanced with various types and concentrations of tahini
M Dzhivoderova-Zarcheva, K Nikovska, S Ivanova, E Dimitrova
International Journal of Gastronomy and Food Science 36, 100925, 2024
2024
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting
R Gencheva, M Petrova, P Kraleva, S Hadjidekova, M Radanova, ...
Cancer Reports 7 (2), e1966, 2024
2024
68 A pictorial view on false positive findings of Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable …
MD Borislav Chaushev, R Marinov, V Nikolov, MD Georgi Todorov, ...
Hellenic Journal of Nuclear Medicine, 2024
2024
Patient resilience and distress level prior to chemotherapy based on time estimation.
P Kraleva, M Petrova, T Popov, NV Conev, E Dimitrova, RK Ruseva, ...
Journal of Clinical Oncology 41 (16_suppl), e24184-e24184, 2023
2023
PI3KCA mutation prevalence and outcome among patients with metastatic breast cancer in Bulgaria treated with first-line endocrine therapy.
R Gencheva, S Hadjidekova, M Petrova, D Krustev, P Kraleva, ...
Journal of Clinical Oncology 41 (16_suppl), e13005-e13005, 2023
2023
P-216 Serum levels of HMGB1 might have a predictive role for neoadjuvant radiotherapy combined with chemotherapy in rectal cancer patients
T Radeva-Petkova, E Encheva, G Mihaylova, D Palamudova, S Bilyukova, ...
Annals of Oncology 33, S326, 2022
2022
Impact of travel burden on overall survival in patients with lung cancer.
DS Stoyanov, I Tonev, E Dimitrova, T Panayotova, R Manev, I Donev, ...
Journal of Clinical Oncology 40 (16_suppl), 6522-6522, 2022
2022
Key Apoptosis Signaling Pathways In Malignant Diseases
T Panayotova, D Stoyanov, R Manev, M Maneva, B Stefanova, ...
Varna Medical Forum 10 (3), 9-13, 2021
2021
High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line.
M Petrova, M Eneva, JI Arabadjiev, NV Conev, E Dimitrova, KD Koynov, ...
Journal of Clinical Oncology 38 (15_suppl), e21546-e21546, 2020
2020
Dynamic of time estimation and its relation with levels of distress.
NV Conev, M Ivanova, E Dimitrova, A Yanchev, I Donev
Journal of Clinical Oncology 38 (15_suppl), e19091-e19091, 2020
2020
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20